ArticleThe Journal of antimicrobial chemotherapy2020

Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease.

Valeria Avataneo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.